Sur vs Zimbabwe: Previously treated cases tested for RR-/MDR-TB
Sur
62.0%
in 2024
Zimbabwe
100.0%
in 2024
Sur rank
1st
Zimbabwe rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Sur
- Zimbabwe
How they compare
Zimbabwe currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Zimbabwe's figure about 1.6 times Sur's.
The two have swapped places 4 times across 9 shared years of data; in 2011 it was Zimbabwe ahead.
Sur ranks 1st and Zimbabwe ranks 1st of 1 regions.
Across the 2 decades both report, Sur averaged higher in 1 and Zimbabwe in 1.
Head to head by decade
| Decade | Sur | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 52.4% | 34.7% | 17.7% | Sur |
| 2020s | 76.0% | 98.0% | 22.0% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Sur or Zimbabwe?
- Zimbabwe, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Sur and Zimbabwe?
- 38.0%, with Zimbabwe ahead.
- How many years of comparable data are there for Sur and Zimbabwe?
- 9 years are reported by both, from 2011 to 2024.
- How do Sur and Zimbabwe rank globally for previously treated cases tested for rr-/mdr-tb?
- Sur ranks 1st and Zimbabwe ranks 1st of 1 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.